TABLE 2.

Susceptibilities of clinical isolates of N. gonorrhoeae from male urethritis patients in 2000 and 2001

AntibioticMIC (μg/ml)MIC ratioa
2000 (n = 53)2001 (n = 24)50%90%
50%90%50%90%
Penicillin G0.521221
Piperacillin0.03130.06250.06250.12522
Tazobactam-piperacillin0.06250.1250.06250.12511
Cefixime0.0080.250.03130.2541
Cefteram0.01560.50.06250.2540.5
Cefdinir0.015610.0313121
Cefpodoxime0.015610.125181
Ceftriaxone0.0040.06250.01560.031340.5
Cefodizime0.01560.06250.03130.062521
Aztreonam0.12540.5441
Flomoxef0.522442
Levofloxacin0.2544>416NCb
Spectinomycin44NDcND
Minocycline0.250.5NDND
  • a MIC for 2001/MIC for 2000.

  • b NC, not calculated.

  • c ND, not determined.